Amy Feldman

In this week's edition of InnovationRx, we look at AbbVie's new megadeal, an agentic AI startup saving Medicare $2 million a week, how new student loan rules could degrade healthcare and more.

In this week's edition of InnovationRx, we look at Axsome's growing pipeline, HistoSonics innovative cancer treatment, state litigation over Medicaid work requirements, and more.

The AI juggernaut is all-in on the healthcare industry, launching three new products in the last six months. But it needs to make sure ChatGPT is accurate enough for the millions of people who already use it for health advice.

In this week's edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI's healthcare push, Vertex's $10 billion purchase of Crinetics, and more.

When OpenAI wants to sell the country’s biggest health systems on its healthcare ambitions, it often brings in one person a hospital CEO won’t ignore: Sam Altman.

In this week's edition of InnovationRx, Thyme Care gets new leadership, the intestinal illness spreads, Chai Discovery confirms its $400 million raise, and more.

With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.

In this week's edition of InnovationRx, we look at the havoc of generic drug tariffs, the companies looking to cash in on the coming peptide

In this week's edition of InnovationRx, we look at Fortell's efforts to make a better hearing aid, Abby Care's business getting payment for

E ven before it gets approval for its sleep apnea pill, Apnimed is testing investor appetite.